Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Celgene pays Agios $20M to extend cancer drug pact
Yahoo/AP
Wednesday, October 5, 2011 - 10:51am
tags:
Celgene, Agios Pharmaceuticals, cancer
New label on Genentech's Avastin warns of infertility
Bizjournals.com
Wednesday, October 5, 2011 - 10:50am
tags:
Avastin, Infertility, warnings, Genentech
Biogen MS trial data reveals no safety surprises
Reuters
Wednesday, October 5, 2011 - 10:49am
tags:
Biogen Idec, multiple sclerosis, MS, BG-12
So Many Jobs Are Gone, Pharma Layoffs Dwindle
Pharmalot
Wednesday, October 5, 2011 - 10:47am
tags:
layoffs
Novo Nordisk: Market Fears Create A Buying Opportunity
Seeking Alpha
Wednesday, October 5, 2011 - 10:46am
tags:
Novo Nordisk, diabetes, degludec
Neurocrine notches $20M Abbott milestone payment
Yahoo/AP
Wednesday, October 5, 2011 - 10:45am
tags:
Abbott Laboratories, Neurocrine, endometriosis, Elagolix
FDA to Respond to Bristol-Myers Drug
Yahoo/Zacks.com
Wednesday, October 5, 2011 - 9:58am
tags:
FDA, Bristol-Myers Squibb, Dapagliflozin, diabetes, AstraZeneca
J&J Directors Win Dismissal of Investor ‘Red Flags’ Suit
Bloomberg
Wednesday, October 5, 2011 - 9:56am
tags:
JNJ, investors, recalls, Omnicare
Amgen's Sharer wins big as "peer benchmarking" drives up CEO pay
Fierce Biotech
Tuesday, October 4, 2011 - 1:55pm
tags:
Amgen, Kevin Sharer, executive pay
Transcept Pharmaceuticals Rises on Potential Sleeping Pill Approval
Minyanville
Tuesday, October 4, 2011 - 1:35pm
tags:
Transcept, insomnia, Intermezzo
1 Reason the Street Should Love Gilead Sciences' Earnings
Motley Fool
Tuesday, October 4, 2011 - 1:33pm
tags:
Gilead, earnings
Nektar Bulls Fight Through Pain
TheStreet.com
Tuesday, October 4, 2011 - 1:32pm
tags:
Nektar
Spanish Drugmakers Eye $7 Billion Sale of Bonds Backed by Unpaid Bills
Bloomberg
Tuesday, October 4, 2011 - 1:30pm
tags:
Spain, Novartis, Roche
Biotech Busts And Breakthroughs For September 2011
Forbes
Tuesday, October 4, 2011 - 12:32pm
tags:
Pacific Biosciences, Lexicon Pharmaceuticals, China Pharmaceutical, Momenta, SYNERGY, Caliper Life Sciences, Optimer, MannKind, Pharmasset, Hi-Tech Pharmacal
5 Biotech Stocks Seeing Significant Short Covering
Seeking Alpha
Tuesday, October 4, 2011 - 12:28pm
tags:
Biocryst, BioDelivery Sciences, Cephalon, Biomarin, Immunogen
Contraceptive Injections Double HIV Infection Risk in Study
Bloomberg
Tuesday, October 4, 2011 - 12:22pm
tags:
HIV, Depo Provera, contraceptives
Somaxon Reports Positive FDA Feedback On Silenor OTC Pathway; Stock Surges 37%
RTT News
Tuesday, October 4, 2011 - 12:20pm
tags:
Somaxon, OTC, Silenor, FDA, insomnia
Why Contract Research Organizations Are Hot
Pharmalot
Tuesday, October 4, 2011 - 12:18pm
tags:
CROs
Pfizer Signs Saudi Arabia Pharmaceutical Plant Deal, SPA Says
Bloomberg
Tuesday, October 4, 2011 - 12:16pm
tags:
Pfizer, Saudi Arabia
Bristol-Myers Plans to Continue Growing Company, Chief Says
Bloomberg
Tuesday, October 4, 2011 - 12:16pm
tags:
Bristol-Myers Squibb, Pharma CEOs, Lamberto Andreotti

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.